Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis

E-ISSN： 2212-4055|13|2|134-143

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.13, Iss.2, 2014-05, pp. : 134-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

Current Medicinal Chemistry, Vol. 16, Iss. 36, 2009-12 ,pp. : 4858-4868

Bentham Science Publishers

Access to resources Recommend Favorite

Treating multiple sclerosis with monoclonal antibodies: a 2013 update

By Deiß Annika Brecht Isabel Haarmann Axel Buttmann Mathias

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 313-335

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis

By Gensicke Henrik Leppert David Yaldizli Özgür Lindberg Raija L.P. Mehling Matthias Kappos Ludwig Kuhle Jens

CNS Drugs, Vol. 26, Iss. 1, 2012-01 ,pp. : 11-37

Adis International

Access to resources Recommend Favorite

Therapeutic Monoclonal Antibodies and Multiple Sclerosis: The Essentials

Medicinal Chemistry, Vol. 14, Iss. 2, 2018-02 ,pp. : 144-154

Bentham Science Publishers

Access to resources Recommend Favorite

Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis

Current Medicinal Chemistry, Vol. 17, Iss. 7, 2010-03 ,pp. : 640-650

Bentham Science Publishers

Access to resources Recommend Favorite